Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTO 888 in Idiopathic Pulmonary Fibrosis
NCT00786201Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2008
- Primary completion
- Jan 2012
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of carlumab in idiopathic pulmonary fibrosis (IPF), sponsored by Janssen Pharmaceutical. Started Dec 2008; status: completed.
02
Drugs
carlumab
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00786201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786201.